Search clinical trials for: Placebo to match ranolazine

Total 1467 results

University of Wisconsin, Madison
Washington University School of Medicine; National Heart, Lung, and Blood Institute...

Completed

UW Quitting Using Intensive Treatment Study (QUITS) (QUITS)

Tobacco Dependence

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women (SHAPE2)

Menopause | Aging

United States
Duke University
National Institute on Drug Abuse (NIDA)

Withdrawn

Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment (ENDS-P50)

Nicotine Dependence

United States
Novartis Pharmaceuticals

Completed

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure (ESCAPE-SHF)

Heart Failure

Russian Federation, Germany, Poland
Lundquist Institute for Biomedical Innovation at...
Abbott Nutrition; DaVita Dialysis

Completed

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients (AIONID)

Inflammation | Oxidative Stress | Hypoalbuminemia | Protein-energy Malnutrition | Chronic Kidney Disease (CKD) Hemodialysis

United States
Duke University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)

Cigarette Smoking

United States
Amgen

Completed

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States, Italy, Netherlands, Canada, United Kingdom, Australia, Germany, Czechia, Greece, France
Suzhou Kintor Pharmaceutical Inc,

Completed

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

Alopecia | Male Pattern Hair Loss

United States
Shenox Pharmaceuticals, LLC

Unknown

Ketamine for Major Depressive Disorder

Major Depressive Disorder

United States
Merck Sharp & Dohme LLC

Terminated

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

Parkinson Disease | Idiopathic Parkinson Disease
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Cystic Fibrosis

United States, Australia, Canada, Germany, Switzerland, Israel, Netherlands, Belgium, Italy, United Kingdom, France
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation

Cystic Fibrosis

United States, Canada, France, Spain, Israel, Australia, Austria
Chulalongkorn University

Completed

Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women

Insomniac Postmenopausal Women

Thailand
Canadian Cancer Trials Group
NuBiyota

Withdrawn

PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma (PROMOTE-HN)

Advanced Head and Neck Squamous Cell Carcinoma
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Dengue Hemorrhagic Fever

United States
Cedars-Sinai Medical Center

Completed

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

Hypothalamic Amenorrhea | Estrogen Deficiency | Cardiovascular Disease (CVD)

United States
Janssen Research & Development, LLC

Completed

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States, Belgium, Czechia, Ukraine, Poland, Malaysia, Serbia, Bulgaria, Argentina, Lithuania, Slovakia, Russian Federation, Canada, United Kingdom, Latvia
AstraZeneca
Parexel

Completed

A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects. (EMLA)

Pain

Germany
Hisamitsu Pharmaceutical Co., Inc.

Completed

HKT-500 in Adult Patients With Shoulder Pain (Pain)

Pain

United States
Walter Reed Army Medical Center
Sunovion

Completed

Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP) (CPAPASAP)

Obstructive Sleep Apnea

United States
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects

Cardiovascular Disease | Healthy Male Subjects

United Kingdom
Merck Sharp & Dohme LLC

Completed

Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)

Herpes Zoster
Hjalte Holm Andersen

Completed

Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch

Pruritus

Denmark
Oregon Health and Science University
National Heart, Lung, and Blood Institute (NHLBI); Indiana University

Recruiting

Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up (VCSIP)

Asthma | Pulmonary Function | Wheezing | In Utero Nicotine

United States
Winston Laboratories

Completed

Civamide Patch Safety, Tolerability and PK Study

Healthy Volunteers

United States
Oregon Health and Science University
National Multiple Sclerosis Society

Completed

American Ginseng Treatment for Multiple Sclerosis Related Fatigue

Multiple Sclerosis

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants

Healthy

Netherlands
Shionogi

Completed

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2)

Influenza
Novartis Pharmaceuticals

Completed

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor (RADIANT-2)

Carcinoid Tumor | Malignant Carcinoid Syndrome

France, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)

Hypertension
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device

Asthma

Germany, United Kingdom
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
Boehringer Ingelheim

Completed

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Stroke | Secondary Prevention

Korea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
Merck Sharp & Dohme LLC
Pfizer

Completed

Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)

Hypertension | Diabetes Mellitus, Type 2
Repurposed Therapeutics, Inc.

Completed

The Prevention and Treatment of Nausea Associated With Motion Sickness

Motion Sickness

United States
Abhimanyu Garg

Completed

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

Familial Partial Lipodystrophy

United States
Suzhou Koshine Biomedica, Inc.

Completed

To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia

Alopecia

China
Topivert Pharma Ltd

Completed

Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects

Ulcerative Colitis

United Kingdom
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects

Healthy Subjects

United Kingdom
Region Skane
Vinnova

Completed

PHMB-based Antiseptic Use in Full-thickness Surgical Wounds

Surgical Site Infections

Sweden
Merck Sharp & Dohme LLC

Completed

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Dyslipidemia
University of California, San Francisco

Completed

Symptom Management After Breast Cancer Surgery

Neuropathic Pain | Postmastectomy Pain

United States
Tuula Toljamo
University of Helsinki; University of Oulu

Completed

Smoking Habits and Smoking Cessation in Young Adults

Smoking | Smoking Cessation | Habits

Finland
Duke University
National Institutes of Health (NIH)

Completed

Neurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction (NNN)

Smoking

United States
Virginia Commonwealth University
National Institute on Aging (NIA); University of Virginia

Recruiting

Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure (VA-ART4)

Heart Failure

United States
Merck Sharp & Dohme LLC

Completed

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Type 2 Diabetes Mellitus
Hoffmann-La Roche

Completed

A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers

Healthy Volunteer

France
Novartis

Completed

12-week Efficacy of Indacaterol

Chronic Obstructive Pulmonary Disease

United States
Novartis

Completed

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States, New Zealand, Belgium
Zhejiang Provincial People's Hospital

Not yet recruiting

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Type2 Diabetes | type1diabetes

China

Search clinical trials for: Placebo to match ranolazine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations